Furthermore, tumour growth in a mouse model of head and neck cancer was slowed and eventually stopped with CP treatment, with increased MUL1 expression and decreased Akt phosphorylation confirmed immunohistochemically [150]. Here, MUL1 is linked to head and neck cancer.